Research: Topiramate: review of safety in pregnancy

Medicines Healthcare Products Regulatory Agency

June 20
10:11 2024

This report presents the review of safety data conducted by the MHRA in 2022/2023, the advice of the CHM and the implementation group in 2023 and 2024, and the steps that the MHRA are taking to implement the new safety measures.

Published 20 June 2024

Recent Comments

Follow Us on Twitter

Share This

Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: